PLoS ONE (Jan 2011)

Biomarkers for severity of spinal cord injury in the cerebrospinal fluid of rats.

  • Joanna M Lubieniecka,
  • Femke Streijger,
  • Jae H T Lee,
  • Nikolay Stoynov,
  • Jie Liu,
  • Randy Mottus,
  • Tom Pfeifer,
  • Brian K Kwon,
  • Jens R Coorssen,
  • Leonard J Foster,
  • Thomas A Grigliatti,
  • Wolfram Tetzlaff

DOI
https://doi.org/10.1371/journal.pone.0019247
Journal volume & issue
Vol. 6, no. 4
p. e19247

Abstract

Read online

One of the major challenges in management of spinal cord injury (SCI) is that the assessment of injury severity is often imprecise. Identification of reliable, easily quantifiable biomarkers that delineate the severity of the initial injury and that have prognostic value for the degree of functional recovery would significantly aid the clinician in the choice of potential treatments. To find such biomarkers we performed quantitative liquid chromatography-mass spectrometry (LC-MS/MS) analyses of cerebrospinal fluid (CSF) collected from rats 24 h after either a moderate or severe SCI. We identified a panel of 42 putative biomarkers of SCI, 10 of which represent potential biomarkers of SCI severity. Three of the candidate biomarkers, Ywhaz, Itih4, and Gpx3 were also validated by Western blot in a biological replicate of the injury. The putative biomarkers identified in this study may potentially be a valuable tool in the assessment of the extent of spinal cord damage.